GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 805 filers reported holding GLAXOSMITHKLINE PLC in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,262,000 | -8.3% | 35,352 | -5.5% | 0.20% | -10.1% |
| Q4 2020 | $1,376,000 | -4.1% | 37,402 | -1.9% | 0.23% | -14.6% |
| Q3 2020 | $1,435,000 | -7.8% | 38,116 | -0.1% | 0.27% | -20.3% |
| Q2 2020 | $1,556,000 | +7.6% | 38,156 | 0.0% | 0.34% | -9.7% |
| Q1 2020 | $1,446,000 | -22.8% | 38,156 | -4.3% | 0.37% | +4.8% |
| Q4 2019 | $1,874,000 | +13.6% | 39,891 | -0.3% | 0.35% | -3.0% |
| Q3 2019 | $1,649,000 | – | 39,991 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |